Farallon Capital Management’s FibroGen FGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $4.38M | Sell |
|
|||||
|
2021
Q4 | $13M | Sell |
|
|||||
|
2021
Q3 | $14.8M | Buy |
|
|||||
|
2021
Q2 | $38.3M | Sell |
|
|||||
|
2021
Q1 | $58.4M | Sell |
|
|||||
|
2020
Q4 | $70.5M | Buy |
|
|||||
|
2020
Q3 | $76.1M | Buy |
|
|||||
|
2020
Q2 | $65.9M | Buy |
|
|||||
|
2020
Q1 | $55.6M | Buy |
|
|||||
|
2019
Q4 | $57.9M | Buy |
|
|||||
|
2019
Q3 | $37M | Sell |
|
|||||
|
2019
Q2 | $76.8M | Buy |
|
|||||
|
2019
Q1 | $49.8M | Buy |
|
|||||
|
2018
Q4 | $34.7M | Sell |
|
|||||
|
2018
Q3 | $84.7M | Sell |
|
|||||
|
2018
Q2 | $108M | Hold |
|
|||||
|
2018
Q1 | $79.3M | Buy |
|
|||||
|
2017
Q4 | $78.6M | Buy |
|
|||||
|
2017
Q3 | $59.2M | Buy |
|
|||||
|
2017
Q2 | $34.6M | Buy |
|
|||||
|
2017
Q1 | $16.8M | Sell |
|
|||||
|
2016
Q4 | $16.7M | Buy |
|
|||||
|
2016
Q3 | $4.66M | Buy |
|